MedPath

Sedative Premedication in Coronary Angiography

Not Applicable
Conditions
Sedative Premedication
Coronary Angiography
Interventions
Drug: Placebo Oral Tablet
Registration Number
NCT03576456
Lead Sponsor
Universitair Ziekenhuis Brussel
Brief Summary

Evaluation of the possible positive effect of sedative premedication prior to coronary angiography in regards to pain and anxiety.

Detailed Description

Coronary angiography is an invasive procedure that can cause patient discomfort. Sedative premedication before coronary angiography could be used to reduce anxiety and pain, but evidence is lacking. Previous trials were predominantly conducted in men and in coronary interventions with femoral access. Recently, radial access has become the preferred route for performing coronary angiograms (RIVAL trial) In this setting, sedative premedication could be of interest to reduce radial spasms, patient anxiety and pain.

Recruitment & Eligibility

Status
UNKNOWN
Sex
All
Target Recruitment
264
Inclusion Criteria
  • elective coronary angiography
Exclusion Criteria
  • planned PCI
  • use of sedative medication at home
  • use of alcohol

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Arm && Interventions
GroupInterventionDescription
AlprazolamAlprazolam 0.5 mgPatients receive alprazolam 0.5 mg 1 hour prior to coronary angiography.
Placebo Oral TabletPlacebo Oral TabletPatients receive placebo 1 hour prior to coronary angiography.
Primary Outcome Measures
NameTimeMethod
periprocedural pain: visual analogue scaleAssessed after the coronary angiography, within 4 hours.

pain during to coronary angiography. Assessed after the procedure through a visual analogue scale for pain. The VAS scale is a visual scale ranging from 0 (no pain) to 100 (extreme pain).

preprocedural anxiety: visual analogue scaleAssessed before the coronary angiography

anxiety prior to coronary angiography. Assessed before the procedure through a visual analogue scale for anxiety (VAS-A). The VAS is a visual scale ranging from 0 to 100 with 0 begin no anxiety at all and 100 begin extreme anxiety.

Secondary Outcome Measures
NameTimeMethod
radial spasmduring procedure

spasm of the radial artery as experienced by operator. There is no precise measurement up until today.

vascular site access complicationduring procedure

need to switch to femoral access, assessed by the operator.

Trial Locations

Locations (1)

Adriaan Wilgenhof

🇧🇪

Brussels, Jette, Belgium

© Copyright 2025. All Rights Reserved by MedPath